What is the recommended protocol for a non-contrast Computed Tomography (CT) scan of the adrenal glands?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended protocol for a non-contrast CT scan of the adrenal glands is to use it as the first-line imaging to distinguish benign lesions from those which require further radiologic investigation, as stated in the 2023 guideline endorsed by the AUA 1.

Key Considerations

  • The scan should be performed with the patient in supine position using 2-3mm slice thickness, with images acquired during a single breath-hold to minimize motion artifacts.
  • The scan range should extend from the dome of the diaphragm to the level of the iliac crests, ensuring complete coverage of both adrenal glands.
  • Technical parameters generally include 120 kVp, automatic tube current modulation (typically 100-300 mAs), and a standard soft tissue reconstruction algorithm.
  • No oral or intravenous contrast is administered.
  • Patients should fast for 4-6 hours prior to the examination, though water is permitted.

Diagnostic Value

  • Non-contrast CT is effective for detecting adrenal masses larger than 5mm and characterizing their density (measured in Hounsfield Units), which helps differentiate benign adenomas (typically <10 HU) from other lesions.
  • This protocol is particularly valuable as the initial imaging study for adrenal incidentalomas and for follow-up of known adrenal lesions, as it minimizes radiation exposure while providing essential diagnostic information about adrenal pathology.

Clinical Guidelines

  • According to the 2023 guideline, patients found to have an indeterminate incidental adrenal mass should undergo a non-contrast CT as first-line imaging 1.
  • The guideline also recommends that patients who continue to have an indeterminate adrenal mass on non-contrast CT should undergo second-line imaging with either washout CT or chemical-shift MRI 1.

From the Research

Adrenal Protocol Without Contrast

The recommended protocol for a non-contrast Computed Tomography (CT) scan of the adrenal glands is as follows:

  • The use of non-contrast CT scans is particularly important in patients with a history of allergy to iodinated contrast media 2.
  • In patients with primary aldosteronism and a history of iodine contrast medium allergy, carbon dioxide venography and intraprocedural unenhanced CT can be used for adrenal venous sampling (AVS) 3.
  • The diagnostic performance of CO2-intraprocedural unenhanced CT-AVS is similar to that of conventional AVS with iodine contrast media 3.
  • Non-contrast CT scans can be used to evaluate the preoperative adrenal vein anatomy 3.
  • Intraprocedural unenhanced CT can be used to confirm catheter position in the right adrenal gland 3.

Considerations for Contrast Media

  • The use of contrast agents should be carefully considered in patients at risk of adverse reactions, and alternative methods such as non-contrast CT scans should be used when possible 4, 5, 6.
  • Patients with pre-existing renal impairment are at increased risk of contrast media nephrotoxicity, and measures such as hydration and the use of non-ionic iso-osmolar dimeric or non-ionic low osmolar monomeric contrast media can help reduce this risk 5, 6.
  • The diagnosis of "iodine allergy" is potentially dangerous and can lead to uncertainty in clinical management, and a more specific diagnosis of contrast media allergy should be sought 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Contrast media safety-an update.

European journal of radiology, 2011

Research

Contrast safety in the cancer patient: preventing contrast-induced nephropathy.

Cancer imaging : the official publication of the International Cancer Imaging Society, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.